Literature DB >> 22240164

Churg-Strauss syndrome: case series.

T M Alfaro1, C Duarte, R Monteiro, A Simão, S Calretas, J M Nascimento Costa.   

Abstract

Churg-Strauss syndrome (CSS) is a systemic necrotizing vasculitis of the small and medium vessels, associated with extravascular eosinophilic granulomas, peripheral eosinophilia and asthma. This is a rare syndrome of unknown etiology, affecting both genders and all age groups. CSS patients usually respond well to steroid treatment, although relapses are common after it ends. Timely diagnosis and treatment generally lead to a good prognosis with a 90% survival rate at one year. A brief review of CSS is presented, with particular attention to diagnosis, therapy and recent developments in this area. The authors then report and discuss the clinical, laboratory and imaging characteristics of four patients admitted to an Internal Medicine Department with this diagnosis. The treatment, response and follow-up of the cases are also described.
Copyright © 2011 Sociedade Portuguesa de Pneumologia. Published by Elsevier España. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22240164     DOI: 10.1016/j.rppneu.2011.12.001

Source DB:  PubMed          Journal:  Rev Port Pneumol        ISSN: 0873-2159


  3 in total

1.  Eosinophilic Lung Disease: Accompanied with 12 Cases.

Authors:  Tülin Sevim; Emine Aksoy; Fatma Tokgöz Akyıl; Meltem Çoban Ağca; Nilüfer Aykaç Kongar; Ferhan Özşeker
Journal:  Turk Thorac J       Date:  2015-10-01

Review 2.  Eosinophilic granulomatosis with polyangiitis complicated by cholecystitis: a case report and review of the literature.

Authors:  Lu Ye; Xiaoyong Lu; Jing Xue
Journal:  Clin Rheumatol       Date:  2014-02-11       Impact factor: 2.980

3.  Churg-Strauss syndrome that presented with mediastinal lymphadenopathy and calculous cholecystitis.

Authors:  Jung Yoon Choi; Ji Eun Kim; In Young Choi; Ju Han Lee; Je Hyeong Kim; Chol Shin; Seung Heon Lee
Journal:  Korean J Intern Med       Date:  2015-12-28       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.